See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Treatment of atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system with surgery, intensive chemotherapy, and 3-d conformal radiation
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-ba26-71c4-eee5-4adc80000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://clinicaltrials.gov/ct2/show/NCT00653068
-
-
Intervention
-
Carboplatin
-
-
Intervention
-
Cisplatin
-
-
Intervention
-
Cyclophosphamide
-
-
Intervention
-
Etoposide
-
-
Intervention
-
Etoposide phosphate
-
-
Intervention
-
Methotrexate
-
-
Intervention
-
Thiotepa
-
-
Intervention
-
Vincristine sulfate
-
-
Intervention
-
Radiation therapy
-
-
Additional Topic(s)
-
Antineoplastic combined chemotherapy protocols
-
-
Additional Topic(s)
-
Radiotherapy
-
-
Resource Description
-
PURPOSE: This phase III trial is studying giving combination chemotherapy together with 3-dimensional conformal radiation therapy and an autologous peripheral blood stem cell transplant to see how well it works in treating young patients with atypical teratoid/rhabdoid tumor of the central nervous system.
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Wilkinson, Robert, M.D.
-
-
Topic
-
central nervous system cancer
-
-
Study Population
-
Patients must be 1 through 21 years old.
-
-
Funded by
-
Children's Oncology Group
-
-
Phase
-
Phase 3 clinical trial
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
